Some of these emerging therapies include calcimimetics such as cinacalcet, which help regulate PTH production and manage hypercalcemia, and PTHrP inhibitors, aimed at blocking the peptide involved in tumor growth and metastasis. Here, PTHLH is linked to Hypercalcemia.